You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

FELBAMATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Felbamate

A generic version of FELBAMATE was approved as felbamate by AMNEAL PHARMS on September 13th, 2011.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FELBAMATE?
  • What are the global sales for FELBAMATE?
  • What is Average Wholesale Price for FELBAMATE?
Summary for FELBAMATE
Drug patent expirations by year for FELBAMATE
Drug Prices for FELBAMATE

See drug prices for FELBAMATE

Recent Clinical Trials for FELBAMATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios Grossman, S.A.Phase 3
Instituto Nacional de Salud Publica, MexicoPhase 3
Federal University of São PauloPhase 4

See all FELBAMATE clinical trials

Pharmacology for FELBAMATE
Anatomical Therapeutic Chemical (ATC) Classes for FELBAMATE

US Patents and Regulatory Information for FELBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms FELBAMATE felbamate SUSPENSION;ORAL 202385-001 Dec 16, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms FELBAMATE felbamate TABLET;ORAL 201680-002 Sep 13, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen FELBAMATE felbamate TABLET;ORAL 204595-001 Jan 11, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Lifesciences FELBAMATE felbamate TABLET;ORAL 208970-001 May 30, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ani Pharms FELBAMATE felbamate TABLET;ORAL 202284-001 Nov 4, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novitium Pharma FELBAMATE felbamate SUSPENSION;ORAL 211333-001 May 31, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro FELBAMATE felbamate SUSPENSION;ORAL 206314-001 Jun 16, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.